Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes
about
Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapyAnnulling a dangerous liaison: vaccination strategies against AIDS and tuberculosisStaphylococcal alpha-toxin is not sufficient to mediate escape from phagolysosomes in upper-airway epithelial cells.Development of new tuberculosis vaccines: a global perspective on regulatory issuesThe immunology of tuberculosis: from bench to bedside.Novel recombinant Mycobacterium bovis BCG, ovine atadenovirus, and modified vaccinia virus Ankara vaccines combine to induce robust human immunodeficiency virus-specific CD4 and CD8 T-cell responses in rhesus macaquesBCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.Assessment of immune response to repeat stimulation with BCG vaccine using in vitro PBMC model.The novel tuberculosis vaccine, AERAS-402, induces robust and polyfunctional CD4+ and CD8+ T cells in adults.Secretion of listeriolysin by Brucella suis inhibits its intramacrophagic replication.Role of CD8 T cells in mycobacterial infections.The twin-arginine translocation pathway of Mycobacterium smegmatis is functional and required for the export of mycobacterial beta-lactamases.The Mycobacterium tuberculosis phagosome in human macrophages is isolated from the host cell cytoplasm.The fbpA/sapM double knock out strain of Mycobacterium tuberculosis is highly attenuated and immunogenic in macrophagesIntracellular bacteria as targets and carriers for vaccination.Dendritic cells: immune saviors or Achilles' heel?Surface expression of MPT64 as a fusion with the PE domain of PE_PGRS33 enhances Mycobacterium bovis BCG protective activity against Mycobacterium tuberculosis in miceThe hbhA gene of Mycobacterium tuberculosis is specifically upregulated in the lungs but not in the spleens of aerogenically infected mice.New tuberculosis vaccine development.The tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in miceNext generation: tuberculosis vaccines that elicit protective CD8+ T cellsAdvances in the development of bacterial vector technology.Antigen-presentation and the role of dendritic cells in periodontitis.Novel GMO-Based Vaccines against Tuberculosis: State of the Art and Biosafety ConsiderationsTuberculosis vaccine development: research, regulatory and clinical strategies.Nonclinical Development of BCG Replacement Vaccine Candidates.New issues in tuberculosis.Recombinant Mycobacterium bovis bacillus Calmette-Guerin elicits human immunodeficiency virus type 1 envelope-specific T lymphocytes at mucosal sites.Protective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferonTuberculosis: from genome to vaccine.Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primatesAdvances in tuberculosis vaccine strategies.Vaccine approaches to prevent tuberculosis.Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosisNew drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections.Protection against tuberculosis with homologous or heterologous protein/vector vaccine approaches is not dependent on CD8+ T cellsA heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice.Safety and Immunogenicity of the Recombinant Mycobacterium bovis BCG Vaccine VPM1002 in HIV-Unexposed Newborn Infants in South Africa.Immune Responses to Bacillus Calmette-Guérin Vaccination: Why Do They Fail to Protect against Mycobacterium tuberculosis?
P2860
Q26798372-4EB9CC98-B907-4B9E-965F-0C10CE66C800Q28243702-7F2EEC61-2040-445A-97CB-A808FECDCC7CQ30490001-DDAE6EA8-9DFB-4E25-9F3C-D63BDE188042Q33293376-1973A4CB-7230-4E9A-A713-0E6D79317D9EQ33777367-7E487E20-2252-49BD-B23C-1730203C96C7Q33877458-63BD02DE-3D87-49B4-96A7-4B83766B42CAQ33893983-19F335A9-0691-4990-9A30-A1972C40F515Q33919973-E2F53CD3-A6FF-4018-AA91-3115817A81F1Q33933553-6E732063-B504-486C-8C25-71A390B87B99Q33950119-07975EF6-2FA7-4158-BEC1-983B227EEE99Q34007089-5DB9E8D9-3A69-4217-98C8-2F5B83044B3DQ34007431-9018B724-A60C-4C9B-84C4-4DFDAD9AED19Q34124354-4CE8134D-FD4D-438C-BDEA-0C33900CB133Q34132027-4AB4ACC2-0D95-4705-AD78-37380436D45DQ34264596-EEA5AED6-6139-420D-83B8-52413B8E7314Q34280918-4D0C4562-B20B-47C9-B93B-D7253275C547Q34304644-339727DB-65AC-4AD8-9575-46D95821B947Q34309667-1E66EBF0-5CB0-4275-80B0-C2CC3FB0C5C0Q34601730-89DDE08C-E2E2-4318-8459-C6CD4A8A2B8AQ34974749-24AFCA92-DDC5-4B90-B1C9-54109FFDEF1AQ35043659-110F7F22-C9BA-4C55-8EAB-E1C65EFF27F0Q35099708-7E29DD34-01AB-431E-8B71-C9F5630721B7Q35193532-7651E210-6F7B-4BCD-9D2A-A3CD86795F88Q35755297-E43AA6B3-968C-4350-BE39-E97E66015086Q35826779-264CE925-7349-4E7A-BD95-FC3497C3193EQ35873788-70FBFBE5-7F69-4580-89E2-DB1E89E67119Q35890636-DE5781C1-2AB4-46A4-9EC8-59385CD894BDQ35915970-A6E3B689-BFFF-4E19-96CB-29699A7353BCQ35946884-8DCF3F62-9641-4FEA-AF10-C43EF8E8FE68Q35949758-9FF32260-FFB0-4771-A218-24FA3BF29321Q36238724-59F22CDF-8979-41B9-874C-CEE54291DAFBQ36439961-FCD47DCB-6699-43A7-9F54-4B8C9B593D0AQ36482518-C8E7FF39-E1CD-49E8-A48D-EF5126D5283CQ36570685-CCC4A2E7-12AC-4F9D-8849-EC31CC644ED8Q37075418-B5013C59-033F-4EDA-BBA9-7E07908EC8F2Q37150326-D7BA1465-6091-412C-A72E-F5054B354735Q37218080-F340DDA6-286E-41BF-8896-9B95E73A4619Q37623702-EBCDAB9F-C333-45D6-8E19-A66A0FC5E659Q37633072-69FC55CB-142F-4531-8085-EC621DE21677Q37737607-33ABE0DE-129A-4258-8DED-3BB7FDC3BC6C
P2860
Mycobacterium bovis Bacille Calmette-Guérin strains secreting listeriolysin of Listeria monocytogenes
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Mycobacterium bovis Bacille Ca ...... ysin of Listeria monocytogenes
@ast
Mycobacterium bovis Bacille Ca ...... ysin of Listeria monocytogenes
@en
type
label
Mycobacterium bovis Bacille Ca ...... ysin of Listeria monocytogenes
@ast
Mycobacterium bovis Bacille Ca ...... ysin of Listeria monocytogenes
@en
prefLabel
Mycobacterium bovis Bacille Ca ...... ysin of Listeria monocytogenes
@ast
Mycobacterium bovis Bacille Ca ...... ysin of Listeria monocytogenes
@en
P2093
P2860
P356
P1476
Mycobacterium bovis Bacille Ca ...... ysin of Listeria monocytogenes
@en
P2093
P2860
P304
P356
10.1073/PNAS.95.9.5299
P407
P577
1998-04-01T00:00:00Z